Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

JP:

I understand your frustration and I agree that Management had no right to acquire expensive assets at this time. And it looks like LymPro's true upside is still unknown (yet to be determined since its not CLIA certified nor FDA approved either); so they need assets that can produce revenue down the road.

I need to hear whats going on with the ESS govt. funding and the MSPrecise tax credit conversion...still holding out hope there (reminder - see below).

"ESS is currently being developed with support from a grant from the Armed Forces Institute for Regenerative Medicine (AFIRM). The AFIRM grant was awarded to support the IND and initial clinical studies. Upon execution of its option, Amarantus anticipates initiating a10 patient, Phase 1/2a clinical study, evaluating the efficacy of ESS vs. meshed split thickness autograft (AG) in the second quarter of 2015"

"On November 10, 2014 DioGenix was awarded a $7.45 million 'Grow New Jersey Assistance Tax Credit' ("Grow NJ Tax Credit") from the State of New Jersey to facilitate the establishment of a laboratory in Camden, New Jersey. By statute, Diogenix can sell the Grow NJ Tax Credit in whole or in part for a minimum of 75 percent of its face value, subject to certain conditions. Amarantus intends to immediately evaluate the sale of these tax credits".

Stay strong....taking a few steps back to take many steps forward.